Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Clinical trial NCT00394173 · COMPLETED

Trial details

NCT number: NCT00394173
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome With Diarrhea (IBS-D)

Start date: 2006-09-01
Primary completion: 2007-10-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.